К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

Adenocarcinoma on a pathology report: what the diagnosis means

Adenocarcinoma is cancer that starts in gland cells. How it is written on a pathology report, what ‘moderately differentiated’ and G2 mean, and what comes next.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026

In short

Adenocarcinoma is a malignant tumor that starts in gland cells, which normally make mucus or other fluids. It is one of the most common cancer types, but the word itself tells you nothing about stage or outlook.

How it appears in your report

The tumor type usually comes first in the diagnosis line, next to the organ and the grade:

  • ‘Moderately differentiated adenocarcinoma of the colon (G2)’.
  • ‘Lung adenocarcinoma, acinar pattern’ — after the type, the pathologist may name the growth pattern.
  • ‘Adenocarcinoma, low grade’ — the way grade is recorded for colorectal cancer under the 2019 WHO classification.
  • ‘Invasive adenocarcinoma’ — the tumor has grown beyond the cell layer where it started, unlike carcinoma in situ.

What it means

Adenocarcinoma is a type of carcinoma, a cancer of epithelial cells. According to the US National Cancer Institute, most cancers of the breast, colon and prostate are adenocarcinomas. In the lung, it starts in mucus-making cells. In the esophagus, the American Cancer Society notes that adenocarcinoma is most often found in the lower third, and it is now the most common type of esophageal cancer in the US.

Terms like ‘well’, ‘moderately’ and ‘poorly differentiated’ describe the tumor grade. For colorectal adenocarcinoma, the 2019 WHO classification recommends a two-tier system: low grade (formerly well to moderately differentiated) and high grade (formerly poorly differentiated).

Does it affect treatment

Yes, but not by itself. Adenocarcinoma of the lung, stomach and breast are different diseases treated in different ways. The tumor type decides which IHC and molecular tests are ordered: with lung adenocarcinoma, for example, doctors usually look for mutations that guide targeted therapy (see the article on mutations in lung cancer). If a metastasis of adenocarcinoma is found first, IHC helps identify the organ of origin. Your treating doctor or tumor board puts the plan together based on the stage and all results.

Questions to ask your doctor

  • Is this the final tumor type, or is IHC needed to confirm it?
  • Which molecular tests are needed for my adenocarcinoma, and have they been done?
  • What is the grade, and does it matter in my case?

If you have your report but are not sure what it means for you, we can go through it in a new diagnosis consultation.

Sources

  1. What Is Cancer? — National Cancer Institute (NCI), 2026
  2. What Is Lung Cancer? — American Cancer Society, 2024
  3. What Is Cancer of the Esophagus? — American Cancer Society, 2025
  4. Histological grade of adenocarcinoma — International Collaboration on Cancer Reporting (ICCR), based on the WHO classification 2019

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles